Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2318381 | 1.00 | AKR1B1 (0.40) | AKR1B1USP2SLCO1B1LMNAL3MBTL1 | |
| SCHEMBL2316305 | 0.84 | AKR1B1 (0.39) | AKR1B1USP2SLCO1B1LMNAPAX8 | |
| SCHEMBL14151526 | 0.81 | — | — | |
| SCHEMBL2316111 | 0.80 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL319227 | 0.75 | AKR1B1 (0.57) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL447075 | 0.75 | AKR1B1 (0.57) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL5319919 | 0.75 | AKR1B1 (0.57) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL16600332 | 0.75 | AKR1B1 (0.57) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL1658629 | 0.75 | AKR1B1 (0.57) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL25916469 | 0.75 | AKR1B1 (0.57) | AKR1B1LMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020239083-A1 | AEROSOL GENERATION OR SMOKING SYSTEM, OR ELECTRONIC CIGARETTE AND DEVICE THEREOF | 钟术光 | 2020-12-03 | — | — | WO | claimed |
| CN-104826132-B | A kind of bionical siRNA micelle nanos compound and application | 南通大学 | 2018-07-24 | — | — | CN | claimed |
| CN-103830745-B | Preparation and application of quantum dot-based multifunctional nano siRNA (Small Interfering Ribonucleic Acid) carrier system | 南通大学 | 2017-05-17 | — | — | CN | claimed |
| CN-104826132-A | Bionic siRNA micelle nano compound and application thereof | UNIV NANTONG | 2015-08-12 | — | — | CN | claimed |
| CN-103830745-A | Preparation and application of quantum dot-based multifunctional nano siRNA (Small Interfering Ribonucleic Acid) carrier system | UNIV NANTONG | 2014-06-04 | — | — | CN | claimed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-116270718-A | Glycan therapeutic and methods of treatment | DSM营养产品有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| WO-2020239083-A1 | AEROSOL GENERATION OR SMOKING SYSTEM, OR ELECTRONIC CIGARETTE AND DEVICE THEREOF | 钟术光 | 2020-12-03 | — | — | WO | disclosed |
| US-20200362380-A1 | Novel Biomolecule and Methods of Manufacturing Thereof | ABECASSIS DAVID (US) | 2020-11-19 | — | — | US | disclosed |
| US-20120315373-A1 | METHODS FOR PRODUCING AMINO-SUBSTITUTED GLYCOLIPID COMPOUNDS | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2012-12-13 | — | — | US | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20100028469-A1 | Extracts of Cranberry and Methods of Using Thereof | HERBALSCIENCE GROUP, LLC (US) | 2010-02-04 | — | — | US | disclosed |
| US-20090285919-A1 | Rice Bran Extracts for Inflammation and Methods of Use Thereof | HALPERN, BARUCH | 2009-11-19 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315373-A1 | METHODS FOR PRODUCING AMINO-SUBSTITUTED GLYCOLIPID COMPOUNDS | AGPAT2, ACMSD, ABHD5 | AKR1B1 902/4885USP2 2768/4885SLCO1B1 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.